​EQA Summary Reports

​EQAsia publishes an executive summary report after each EQA trial.

Below you may find the reports that have been published to date.

Our EQA summary reports offer a valuable overview of external quality assessment results, helping laboratories and professionals enhance their performance and maintain the highest standards of quality in their work.

 

​EQA1 summary report

Salmonella spp and E. coli (updated December 2021, see erratum)

EQA2 summary report

Klebsiella pneumoniae, Shigella spp., Acinetobacter spp., and Staphylococcus aureus - 2021​

​​​​EQA3 summary report

Salmonella spp., Escherichia coli, Pseudomonas aeruginosa, Campylobacter jejuni / C. coli, Enterococcus faecium / E. faecalis and Streptococcus pneumoniae - 2021.

​Erratum for EQA1 summary report

​​​EQA4 summary report

Klebsiella pneumoniae, Acinetobacter spp. and Staphylococcus aureus - 2022

​EQA5 summary report

Campylobacter jejuni / C. coli, Enterococcus faecium / E. faecalis and Streptococcus pneumoniae - 2022

EQA6 summary report

E.coli,​Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus - 2023

EQA7 summary report

Salmonella spp., Enterococcus spp., Campylobacter spp., and Neisseria gonorrhoeae - 2023

Matrix

Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

1st Matrix EQA summary report

Selective isolation of presumptive ESBL-, AmpC- and carbapenemase-producing Escherichia coli from cultures mimicking meat samples - 2021

​2nd Matrix EQA summary report

Selective isolation of presumptive ESBL-, AmpC- and carbapenemase-producing Escherichia coli from cultures mimicking meat samples - 2022

3rd Matrix EQA summary report

Selective isolation of presumptive ESBL-, AmpC- and carbapenemase- producing Escherichia coli from cultures mimicking meat samples - 2023​​